TROW
37
8
APA
30
5
JNJ
30
4
EXPE
83
8
CI
35
2
INTU
54
2
AIZ
61
5
MMC
46
5
EMR
57
7
DVA
62
5
MKC
54
3
ADT
12
2
MTB
38
4
VIX
41
-11
D
32
10
LRCX
56
4
ORCL
49
3
SYF
78
7
JNPR
59
3
ZTS
38
4
TROW
37
8
APA
30
5
JNJ
30
4
EXPE
83
8
CI
35
2
INTU
54
2
AIZ
61
5
MMC
46
5
EMR
57
7
DVA
62
5
MKC
54
3
ADT
12
2
MTB
38
4
VIX
41
-11
D
32
10
LRCX
56
4
ORCL
49
3
SYF
78
7
JNPR
59
3
ZTS
38
4
Financhill
Back

UroGen Pharma Vs. Royalty Pharma PLC Industry Stock Comparison

Sell
22

URGN
UroGen Pharma

Last Price:
$10.66
Seasonality Move:
-3.79%
Sell
32

RPRX
Royalty Pharma PLC

Last Price:
$24.97
Seasonality Move:
1.44%
Sell
22
UroGen Pharma (URGN) is a Sell

Is UroGen Pharma a Buy, Sell or Hold?

  • The current UroGen Pharma [URGN] share price is $10.67. The Score for URGN is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • URGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Royalty Pharma PLC (RPRX) is a Sell

Is Royalty Pharma PLC a Buy, Sell or Hold?

  • The current Royalty Pharma PLC [RPRX] share price is $24.94. The Score for RPRX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • RPRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

URGN Stock Price Chart

What is UroGen Pharma's stock price today?

  • The UroGen Pharma share price today is $10.67
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and URGN is experiencing slight selling pressure.

RPRX Stock Price Chart

What is Royalty Pharma PLC's stock price today?

  • The Royalty Pharma PLC share price today is $24.94
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

URGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.36 Sell
Relative Strength Index (14 RSI): 30.29 Sell
Chaikin Money Flow: -612616 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.1 - 12.42) Sell
Bollinger Bands (100): (11.7 - 14.2) Sell

RPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 39.23 Sell
Chaikin Money Flow: 5676845 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.09 - 26.47) Sell
Bollinger Bands (100): (26.05 - 28.27) Sell

URGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.14 Sell
20-day SMA: 11.89 Sell
50-day SMA: 12.03 Sell
200-day SMA: 13.95 Sell
8-day EMA: 11.14 Sell
20-day EMA: 11.58 Sell
50-day EMA: 12.09 Sell
200-day EMA: 13.45 Sell

RPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.88 Buy
20-day SMA: 25.71 Sell
50-day SMA: 26.45 Sell
200-day SMA: 27.59 Sell
8-day EMA: 24.95 Sell
20-day EMA: 25.48 Sell
50-day EMA: 26.23 Sell
200-day EMA: 27.55 Sell

UroGen Pharma Earnings Growth & URGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.42 per share.

Royalty Pharma PLC Earnings Growth & RPRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.24 per share, and an increase next year of $0.22 per share.

UroGen Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Royalty Pharma PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):